Recurrent neurosurgical site infection by extensively drug-resistant

Cefiderocol is a new siderophore cephalosporin designed to be active against extensively resistant Gram-negative bacteria; however, clinical studies are limited to complicated urinary tract infections, pneumonia, and intra-abdominal infections. To date, no data are available on neurosurgical site infections. We present a case of a patient successfully cured with Cefiderocol for a neurosurgical site infection due to extensively resistant Cefiderocol is a promising antibiotic for complicated infections due to multidrug resistant gram-negative bacteria.